What is Syngene International Ltd (SYNGENE) share price today?

Syngene International Ltd (SYNGENE) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/SYNGENE for the latest live price, technical analysis, and AI-powered insights.

How to analyse SYNGENE stock?

VestAI provides comprehensive SYNGENE stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Syngene International Ltd in?

Syngene International Ltd (SYNGENE) is in the Healthcare sector, Healthcare Research Analytics & Technology industry on the NSE.

Syngene International Ltd

Name: Syngene International Ltd (SYNGENE) Financial Metrics
Creator: VestAI

SYNGENE

NSE· Healthcare

₹417.45

-1.95 (-0.46%)

Updated 11:29 am IST

52W Low · ₹380.0052W High · ₹728.60

Near 52W Low

Market Cap

₹17450.38L Cr

Volume

4.88L

Prev Close

₹419.40

ISIN

INE398R01022

Orion Score

Fundamentals-based quality & risk · not a recommendation

65/100

Quality

Syngene International Ltd scores 65/100 (Quality) on the Orion Score — strong business quality (73), moderate growth (56), strong balance-sheet safety (85) and rich valuation (28). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 2.1× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 5/9Altman Z Safe(5.86)Beneish M Clean(-2.93)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

35/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.09x — lean balance sheet

QUALITY

Low Quality

ROCE 9.6% — poor capital efficiency

MOMENTUM

Bearish

RSI 40.0 — weak momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 55.25
ROCE: 9.57%
ROE (1Y): 6.62%
D/E Ratio: 0.09x
OPM: 20.55%
TTM EPS: ₹7.86
Dividend Yield: 29.00%
Qtrly Sales: ₹1,036.50 Cr
Qtrly Profit: ₹147.90 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹1,036.5	₹147.9	20.6%	₹3.67
Q3 2026	₹917.1	₹15	12.9%	₹0.37
Q1 2026	₹874.5	₹86.7	11.4%	₹2.15
Q4 2025	₹1,018	₹183.3	23.8%	₹4.56
Q3 2025	₹943.7	₹131.1	18.4%	₹3.26

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹3,738.7	₹316.7	₹912.6	14.1%
FY 2025	₹3,642.4	₹496.2	₹1,145.6	16.8%
FY 2024	₹3,369.5	₹510	₹1,091.8	19.2%
FY 2023	₹3,080.2	₹464.4	₹994.6	20.1%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
SYNGENE ★	₹17,450 Cr	55.25	9.57%	6.62%	0.09x	20.55%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹88,228 Cr	25.64	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,372 Cr	108.60	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,615 Cr	38.42	36.14%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹6,795.9	₹6,151.6	₹5,831	₹5,563.8
Equity	₹4,726.8	₹4,257.7	₹3,618	₹3,297.6
Total Debt	₹577.9	₹555.2	₹815.2	₹1,021.6
Cash	₹366.9	₹85.6	₹87	₹261
Net Debt	—	₹56.1	₹488.3	₹528.6
Working Capital	₹890.9	₹814.7	₹1,237.1	₹977

Shareholding Pattern

Q3 FY2026

Promoter

52.68%

FII

14.96%

DII

25.83%

Public

6.22%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q3 FY2026	52.68%	14.96% ↓	25.83% ↑	6.22% ↑
Q2 FY2026	52.68%	16.31% ↓	24.62% ↑	6.08% ↓
Q1 FY2026	52.68% ↓	16.51% ↓	24.05% ↑	6.45% ↑
Q4 FY2025	52.74%	19.47% ↓	21.5% ↑	5.99% ↓
Q3 FY2025	52.74% ↓	20.65% ↓	19.52% ↑	6.79% ↑
Q2 FY2025	54.72%	20.72% ↑	17.49% ↑	6.74% ↓
Q1 FY2025	54.72% ↓	20.64% ↓	16.78% ↑	7.44% ↓
Q4 FY2024	54.79%	20.92%	15.8%	8.18%

Corporate Actions

Ex-Date	Action	Details
2026-06-25	DIVIDEND	Dividend - Rs 1.25 Per Share

Funds Holding This Stock

98 mutual fund schemes

Nippon India Focused Fund Direct GrowthRELIANCE

3.03%

₹254 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

2.99%

₹193 Cr

Mirae Asset Focused Fund Direct GrowthMIRAE_ASSET

2.67%

₹174 Cr

Tata India Pharma & Healthcare Fund Direct GrowthTATA

2.65%

₹37 Cr

ICICI Prudential Children's Fund Direct GrowthICICI_PRUDENTIAL

2.46%

₹35 Cr

Old Bridge Flexi Cap Fund Direct GrowthOld Bridge

2.08%

₹4 Cr

Nippon India Innovation Fund Direct GrowthRELIANCE

2.05%

₹58 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

1.85%

₹6 Cr

Nippon India Pharma Fund Direct GrowthRELIANCE

1.79%

₹155 Cr

DSP Focused Direct Plan GrowthDSP

1.76%

₹44 Cr

Analyse SYNGENE with Orion AI

Ask: "Is Syngene International Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Syngene International Ltd (SYNGENE) Stock

Syngene International Ltd is listed on the NSE under the Healthcare sector, Healthcare Research Analytics & Technology industry. ISIN: INE398R01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.